Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $61.5B |
| FY2017, ended Dec 31, 2017 | $67.8B |
| FY2018, ended Dec 31, 2018 | $59.2B |
| FY2019, ended Dec 31, 2019 | $70.3B |
| FY2020, ended Dec 31, 2020 | $69.3B |
| FY2021, ended Dec 31, 2021 | $82.4B |
| FY2022, ended Dec 31, 2022 | $91.2B |
| FY2023, ended Dec 31, 2023 | $91.7B |
| FY2024, ended Dec 31, 2024 | $111B |
| FY2025, ended Dec 31, 2025 | $122B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $126B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $31.5B |
| FY2017, ended Dec 31, 2017 | $32.2B |
| FY2018, ended Dec 31, 2018 | $32.7B |
| FY2019, ended Dec 31, 2019 | $34.2B |
| FY2020, ended Dec 31, 2020 | $36.0B |
| FY2021, ended Dec 31, 2021 | $40.9B |
| FY2022, ended Dec 31, 2022 | $43.1B |
| FY2023, ended Dec 31, 2023 | $49.7B |
| FY2024, ended Dec 31, 2024 | $55.8B |
| FY2025, ended Dec 31, 2025 | $59.4B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $60.8B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income |
|---|---|
| FY2016, ended Dec 31, 2016 | $4.13B |
| FY2017, ended Dec 31, 2017 | $3.86B |
| FY2018, ended Dec 31, 2018 | $3.96B |
| FY2019, ended Dec 31, 2019 | $4.45B |
| FY2020, ended Dec 31, 2020 | $3.53B |
| FY2021, ended Dec 31, 2021 | $8.53B |
| FY2022, ended Dec 31, 2022 | $5.25B |
| FY2023, ended Dec 31, 2023 | $9.03B |
| FY2024, ended Dec 31, 2024 | $9.27B |
| FY2025, ended Dec 31, 2025 | $10.3B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $11.3B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $985M |
| FY2017, ended Dec 31, 2017 | $728M |
| FY2018, ended Dec 31, 2018 | $1.25B |
| FY2019, ended Dec 31, 2019 | $1.54B |
| FY2020, ended Dec 31, 2020 | $1.75B |
| FY2021, ended Dec 31, 2021 | $1.66B |
| FY2022, ended Dec 31, 2022 | $2.01B |
| FY2023, ended Dec 31, 2023 | $2.62B |
| FY2024, ended Dec 31, 2024 | $2.55B |
| FY2025, ended Dec 31, 2025 | $2.47B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $2.63B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $13.1B |
| FY2017, ended Dec 31, 2017 | $12.6B |
| FY2018, ended Dec 31, 2018 | $12.6B |
| FY2019, ended Dec 31, 2019 | $14.9B |
| FY2020, ended Dec 31, 2020 | $14.9B |
| FY2021, ended Dec 31, 2021 | $16.2B |
| FY2022, ended Dec 31, 2022 | $14.9B |
| FY2023, ended Dec 31, 2023 | $14.5B |
| FY2024, ended Dec 31, 2024 | $15.2B |
| FY2025, ended Dec 31, 2025 | $17.2B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $17.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 16.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 466M |
| FY2017, ended Dec 31, 2017 | 464M |
| FY2018, ended Dec 31, 2018 | 458M |
| FY2019, ended Dec 31, 2019 | 452M |
| FY2020, ended Dec 31, 2020 | 450M |
| FY2021, ended Dec 31, 2021 | 426M |
| FY2022, ended Dec 31, 2022 | 414M |
| FY2023, ended Dec 31, 2023 | 406M |
| FY2024, ended Dec 31, 2024 | 400M |
| FY2025, ended Dec 31, 2025 | 390M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 388M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 31, 2017 | $801M |
| FY2018, ended Dec 31, 2018 | $1.04B |
| FY2019, ended Dec 31, 2019 | $1.53B |
| FY2020, ended Dec 31, 2020 | $523M |
| FY2021, ended Dec 31, 2021 | $4.86B |
| FY2022, ended Dec 31, 2022 | $2.89B |
| FY2023, ended Dec 31, 2023 | $2.41B |
| FY2024, ended Dec 31, 2024 | $1.80B |
| FY2025, ended Dec 31, 2025 | $3.69B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $4.18B |
Valuation
At current price- Market Cap
- $138B
- P/E
- 12.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.3×
- Price / Book
- 1.9×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $60.8B
- Revenue Growth YoY
- 8.2%
- Revenue CAGR 3Y
- 11.3%
- Revenue CAGR 5Y
- 10.5%
- EPS Growth YoY
- 36.2%
- Net Income Growth YoY
- 33.6%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 18.6%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 16.2%
Earnings
Trailing 12 months- Net Income
- $11.3B
- EPS (diluted)
- $28.27
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $2.63B
- Total Debt
- $17.5B
- Net Debt
- $14.8B
- Total Assets
- $275B
- Total Liabilities
- $196B
- Shareholders' Equity
- $73.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $15.2B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 0.8%
- Dividend / Share
- $3.01
- Beta (5Y)
- 0.36
Every ratio is calculated from the company’s reported figures.